FXYD1 and familial primary hypomagnesemia: Several members of the FXYD family have been linked to major human diseases, including heart failure (FXYD1), hypomagnesemia (FXYD2), cancer (FXYD3, FXYD5), and schizophrenia (FXYD6), making them attractive specific targets for future therapies.